Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 51

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

p28, an Anionic Cell-Penetrating Peptide, Increases the Activity of Wild Type and Mutated p53 without Altering Its Conformation

Yamada, Tohru, Das Gupta, Tapas K., Beattie, Craig W. · 2013 · Molecular Pharmaceutics

Abstract

p28, a cell penetrating peptide, binds to the DNA binding domain (DBD) of p53, inducing a post-translational increase in intracellular levels of wild type and mutant p53 activating pathways that inhibit cancer cell proliferation at G2/M. Cancer cells respond to p28 with an increase in p53 activity, except when mutations either alter DNA contact or completely unfold the DBD. The increase in p53 activity is accompanied by a significant reduction in the level of the E3 ligase COP1, with no alteration in p53 conformation. This suggests p28 can activate p53 over a wide range of conformational mutations by inhibiting the binding of COP1 to p53.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/mp400221r

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 44

  1. Prives C., 1999, J. Pathol., 187, 112, 10.1002/(SICI)1096-9896(199901)187:1<112::AID-PATH250>3.0.CO;2-3 · doi:10.1002/(sici)1096-9896(199901)187:1<112::aid-path250>3.0.co;2-3
  2. Vogelstein B., 2000, Nature, 408, 307, 10.1038/35042675 · DOI · Paper page
  3. Blagosklonny M. V., 1997, Oncogene, 15, 1889, 10.1038/sj.onc.1201374 · doi:10.1038/sj.onc.1201374
  4. Freed-Pastor W. A., 2012, Genes Dev., 26, 1268, 10.1101/gad.190678.112 · DOI · Paper page
  5. Bullock A. N., 2001, Nat. Rev. Cancer, 1, 68, 10.1038/35094077 · DOI · Paper page
  6. Muller P., 2008, Oncogene, 27, 3371, 10.1038/sj.onc.1211010 · DOI · Paper page
  7. Wu X., 1993, Genes Dev., 7, 1126, 10.1101/gad.7.7a.1126 · DOI · Paper page
  8. Ashcroft M., 2000, Mol. Cell. Biol., 20, 3224, 10.1128/MCB.20.9.3224-3233.2000 · DOI · Paper page
  9. Leng R. P., 2003, Cell, 112, 779, 10.1016/S0092-8674(03)00193-4 · DOI · Paper page
  10. Dornan D., 2004, Nature, 429, 86, 10.1038/nature02514 · DOI · Paper page
  11. Dornan D., 2006, Science, 313, 1122, 10.1126/science.1127335 · DOI
  12. Su C. H., 2011, Cancer Res., 71, 884, 10.1158/0008-5472.CAN-10-2518 · doi:10.1158/0008-5472.can-10-2518
  13. Dornan D., 2004, Cancer Res., 64, 7226, 10.1158/0008-5472.CAN-04-2601 · DOI
  14. Vu B. T., 2011, Curr. Top. Microbiol. Immunol., 348, 151
  15. Blagosklonny M. V., 2005, Cancer Res., 65, 7386, 10.1158/0008-5472.CAN-04-3433 · DOI
  16. Li D., 2011, Cell Death Differ., 18, 1904, 10.1038/cdd.2011.71 · DOI · Paper page
  17. Bykov V. J., 2005, J. Biol. Chem., 280, 30384, 10.1074/jbc.M501664200 · DOI · Paper page
  18. Taylor B. N., 2009, Cancer Res., 69, 537, 10.1158/0008-5472.CAN-08-2932 · DOI · Paper page
  19. Yamada T., 2009, Mol. Cancer Ther., 8, 2947, 10.1158/1535-7163.MCT-09-0444 · DOI
  20. Jia L., 2011, Cancer Chemother. Pharmacol., 68, 513, 10.1007/s00280-010-1518-3 · DOI
  21. Bizzarri A. R., 2011, Int. J. Nanomed., 6, 3011, 10.2147/IJN.S26155 · DOI · Paper page
  22. Yamada T., 2013, Br. J. Cancer, 108, 2495, 10.1038/bjc.2013.266 · DOI · Paper page
  23. Kichina J. V., 2003, Oncogene, 22, 4911, 10.1038/sj.onc.1206741 · DOI
  24. De Grandis V., 2007, J. Mol. Recognit., 20, 215, 10.1002/jmr.840 · DOI
  25. Bizzarri A. R., 2009, J. Mol. Recognit., 22, 506, 10.1002/jmr.975 · DOI
  26. Kozakov D., 2010, Proteins, 78, 3124, 10.1002/prot.22835 · DOI · Paper page
  27. Zhang C., 1997, J. Mol. Biol., 267, 707, 10.1006/jmbi.1996.0859 · DOI · Paper page
  28. Camacho C. J., 2000, Biophys. J., 78, 1094, 10.1016/S0006-3495(00)76668-9 · DOI
  29. Reynolds C., 2009, Bioinformatics, 25, 413, 10.1093/bioinformatics/btn584 · DOI · Paper page
  30. Yamada T., 2002, Proc. Natl. Acad. Sci. U.S.A., 99, 14098, 10.1073/pnas.222539699 · DOI · Paper page
  31. Punj V., 2004, Oncogene, 23, 2367, 10.1038/sj.onc.1207376 · DOI · Paper page
  32. Wiman K. G., 1991, Oncogene, 6, 1633
  33. Joerger A. C., 2007, Oncogene, 26, 2226, 10.1038/sj.onc.1210291 · DOI · Paper page
  34. Su Y., 2010, Biochemistry, 49, 6009, 10.1021/bi100642n · DOI
  35. Liu S., 2009, BMC Cancer, 9, 162, 10.1186/1471-2407-9-162 · DOI
  36. Vassilev L. T., 2004, Science, 303, 844, 10.1126/science.1092472 · DOI · Paper page
  37. Tovar C., 2013, Cancer Res., 73, 2587, 10.1158/0008-5472.CAN-12-2807 · DOI · Paper page
  38. Monti P., 2011, Mol. Cancer Res., 9, 271, 10.1158/1541-7786.MCR-10-0496 · DOI
  39. Lee M. K., 2012, Cancer Cell, 22, 751, 10.1016/j.ccr.2012.10.022 · DOI
  40. Vaughan C. A., 2012, Genes Cancer, 3, 491, 10.1177/1947601912462719 · DOI
  41. Bourdon J. C., 2007, Br. J. Cancer, 97, 277, 10.1038/sj.bjc.6603886 · DOI · Paper page
  42. Khoury M. P., 2010, Cold Spring Harbor Perspect. Biol., 2, a000927, 10.1101/cshperspect.a000927 · DOI · Paper page
  43. Aoubala M., 2010, Breast Cancer Res., 12, P8, 10.1186/bcr2505 · doi:10.1186/bcr2505
  44. Warso M. A., 2013, Br. J. Cancer, 108, 1061, 10.1038/bjc.2013.74 · DOI · Paper page

Cited by

See all 51

Metadata

Authors
Yamada, T., Das Gupta, T. K., & Beattie, C. W.
Affiliations
Department of Surgery, Division of Surgical Oncology, University of Illinois at Chicago College of Medicine, 840 South Wood Street, Suite 618, Chicago, Illinois 60612, United States
Venue
Molecular Pharmaceutics
Published
2013-08-16
Volume
10
Issue
9
Pages
3375-3383
ISSN
  • 1543-8384
  • 1543-8392
Cited by
51
References
4
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.